Organization Overview
Alternative names
dasiglucagon (Zegalogue) (2021 NDA)
lixisenatide (adlyxin) (2001)
Congenital Hyperinsulinism (Phase 3)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Heart Failure (Phase 2)
Hyperinsulinism (Phase 3)
Hypoglycemia (Phase 3)
Infarction (Phase 2)
Inflammatory Bowel Diseases (Phase 1)
Myocardial Infarction (Phase 2)
Renal Insufficiency (Phase 1)
Short Bowel Syndrome (Phase 3)
Syndrome (Phase 3)